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a microbial feed additive abates 
intestinal inflammation in atlantic 
salmon
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The efficacy of a microbial feed additive (Bactocell®) in countering intestinal inflammation 
in Atlantic salmon was examined in this study. Fish were fed either the additive-coated 
feed (probiotic) or feed without it (control). After an initial 3-week feeding, an inflammatory 
condition was induced by anally intubating all the fish with oxazolone. The fish were
offered the feeds for 3 more weeks. Distal intestine from the groups was obtained at
4 h, 24 h, and 3 weeks, after oxazolone treatment. Inflammatory responses were prom-
inent in both groups at 24 h, documented by changes in intestinal micromorphology,
expression of inflammation-related genes, and intestinal proteome. The control group
was characterized by edema, widening of intestinal villi and lamina propria, infiltration of 
granulocytes and lymphocytes, and higher expression of genes related to inflammatory 
responses, mul1b, il1b, tnfa, ifng, compared to the probiotic group or other time points 
of the control group. Further, the protein expression in the probiotic group at 24 h after 
inducing inflammation revealed five differentially regulated proteins – Calr, Psma5, Trp1, 
Ctsb, and Naga. At 3 weeks after intubation, the inflammatory responses subsided in the 
probiotic group. The findings provide evidence that the microbial additive contributes to 
intestinal homeostasis in Atlantic salmon.
 
 
 
 
Keywords: atlantic salmon, microbial feed additive, Pediococcus acidilactici, probiotic, intestinal inflammation, 
histology, proteins, genes
introduction
Feed ingredients of plant origin have become integral parts of aquafeeds of even carnivorous fish 
species such as Atlantic salmon. Soybean-induced enteritis in farmed fish, which has similarities to 
intestinal enteropathies in human beings (1), has been acknowledged as a major nutritional pathol-
ogy. Soybean contains saponins that cause distal intestinal inflammation (2, 3), which is character-
ized by intestinal fold height shortening, enterocyte supranuclear vacuoles’ disappearance, epithelial 
cell fold fusion, inflammatory cell infiltration into lamina propria, and thickening of lamina propria 
and submucosa (4). Feed-induced abnormal conditions could weaken the vital immune defense 
functions in the intestine. Therefore, intestinal health status can be one of the defining factors of 
fish welfare.
Mammalian studies have demonstrated that exogenous immunomodulatory feed components 
that are intended to improve gut health aid in overcoming feed-induced enteropathy by preventing 
the destruction of epithelial cells as well as an increase of para- and trans-cellular permeability (5). 
Probiotics can improve the intestinal epithelial barrier function by stimulating and stabilizing the 
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gut mucosal immunological barrier (6). They have been found 
to affect the growth of beneficial microorganisms positively and 
alleviate ulcerative colitis in human beings (7). Experimental 
murine models that were used to study colitis also revealed the 
anti-inflammatory properties and proinflammatory cytokine 
activity blocking function of probiotics (8).
The application of probiotics as an alternative disease manage-
ment strategy for farmed fish is documented in several reviews 
(9–11). Although probiotic bacterial administration (lactic acid 
and Bacillus types) is a promising approach to maintaining the 
intestinal health of fish, only some studies have assessed this 
aspect (12–14). The ability of microalga (Chlorella vulgaris) and 
yeast (Candida utilis) in maintaining intestinal homeostasis and 
combating soybean-induced enteropathy has been described in 
Atlantic salmon (15).
Intestinal inflammation in fish has been studied using 
chemically induced experimental models. In zebrafish, epithelial 
damage, goblet cell depletion, granulocyte influx, and increased 
expression of interleukin-1beta, tumor necrosis factor-alpha, and 
interleukin-10 were the characteristics of oxazolone-induced 
inflammation (16). In the present study, it was hypothesized that 
a microbial feed additive (a lactic acid bacterium – Pediococcus 
acidilactici) could alleviate the oxazolone-induced inflammatory 
responses in Atlantic salmon. The aim of the study was to find the 
differences in immune responses between groups of fish, which 
were fed a microbial additive-coated or phosphate-buffered saline 
(PBS)-coated feeds, at different time points after inflammation. 
The ability of a commercially available microbial feed additive 
in countering the induced inflammation will be discussed based 
on the alterations in micromorphological features, selected 
inflammation-related genes, and expression of proteins in the 
distal intestine (DI) of Atlantic salmon.
Materials and Methods
Fish
Atlantic salmon smolts (Aquagen strain; av. wt. 150 g) obtained 
from Cermaq, Hopen, Bodø, Norway and maintained at the 
Research Station, University of Nordland (UiN), Norway were 
used for the study. A feeding trial was designed with two fish 
groups  –  the test group (Probiotic) was offered microbial feed 
additive-coated feed, and the control group (Control) received 
feed without the additive. Twenty fishes were randomly distrib-
uted into each of the triplicate tanks (500 l) of the two groups. 
The water temperature in the flow-through rearing system was 
7.5°C, and the oxygen saturation was 89%–95%. The study was 
approved by the Norwegian Animal Research Authority (FDU: 
Forsøksdyrutvalget ID 4353), and the handling of fish during 
intubation as well as sampling procedures were according to the 
authorized protocols.
experimental Feeds, Feeding
Bactocell® (lyophilized live lactic acid producing bacterial strain 
P. acidilactici CNCM MA18/5M, Lallemand Animal Nutrition, 
Balgnac, France) was included in the feed for the probiotic group, 
at the recommended rate of 1 × 1010 CFU/kg feed. Briefly, 1 g of 
Bactocell® was suspended in 100 ml of sterile PBS (pH 7.5), and the 
solution was stirred overnight. On the following day, the bacterial 
suspension was spray-coated on 1 kg of commercial feed (Spirit, 
size: 3 mm, Skretting, Norway) that was being mixed thoroughly 
to ensure uniform coating. The microbial additive-coated feed 
was then dried at 30°C for 4 h, cooled at room temperature for 
30 min, sealed and stored at 4°C in plastic bags until further use. 
The control feed was prepared similarly, with the exception that 
the feed was spray-coated with sterile PBS without the Bactocell®. 
Fresh batches of feeds were prepared and stored every week.
Fish in triplicate tanks of the control and probiotic groups 
received their respective feeds for a period of three weeks (initial 
feeding), prior to carrying out the intubation, and for an addi-
tional 3 weeks starting from 48 h after the intubation. The feeds 
were dispensed from a programed automatic feeder (Arvo-Tec, 
Huutokoski, Finland) at a rate of 1.5% of body weight per day.
induction of intestinal inflammation
At the end of the first 3-week feeding period, a chemical allergen, 
oxazolone (4-ethoxymethylene-2-phenloxazol-5-one; Sigma-
Aldrich, St. Louis, USA) was anally intubated to induce inflam-
mation. The fishes were first starved for 48 h and then anesthetized 
using MS-222 (80  mg/l  –  Tricaine methanesulphonate, Argent 
Chemical Laboratories, Redmond, USA). Briefly, 0.5% oxazolone 
in 50% ethanol was used for the anal intubation – each fish of 
average weight 150  g received 1  mg of oxazolone in 200 μl of 
the inoculum. This intubation dosage was determined based on 
similar studies on zebrafish (16).
In order to deliver the pre-determined volume of allergen into 
the DI, a veterinary sterile Buster cat catheter (1.3 mm × 130 mm, 
Kruuse Norge AS, Drøbak, Norway) fitted to a sterile 1 ml syringe 
was inserted into the anal pore. Following this procedure, and 
after ensuring the successful delivery of the allergen, the fish 
were allowed to recover in separate tanks before returning them 
to their rearing tanks.
sampling
A total of nine fish from each group (three from each triplicate 
tank) were sampled at each time point. The initial samples were 
taken at the end of the first feeding term of 3 weeks, i.e., ahead 
of the intubation. Following induction of inflammation, samples 
were collected at 4 and 24 h, and later after 3 weeks.
Fishes were anesthetized using MS-222 and euthanized before 
collecting the samples. After drawing out blood, the DI was 
dissected out. The anterior portion (5 mm) of DI was fixed for 
the histology study. The remaining segment intended for gene 
expression and proteomic studies was gently flushed with sterile 
PBS to remove the digesta, and placed in microtubes that were 
snap-frozen in liquid nitrogen and stored at −80°C.
histological study
Approximately 5 mm of the distal intestinal samples (n = 6) were 
rinsed with PBS and fixed in 4% phosphate-buffered formal-
dehyde solution (pH 7.2) at 4°C for 24 h. Standard histological 
procedures were adopted for dehydration, processing, and paraf-
fin embedding. The paraffin blocks thus prepared were sectioned 
using a microtome (Microm HM3555, MICROM International 
GmbH, Walldorf, Germany). Five-micrometer thick longitudinal 
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sections were cut and mounted on SuperFrost® slides (Menzel, 
Braunschweig, Germany), and a robot slide stainer (Microm 
HMS 760×, MICROM International GmbH) was used to stain the 
slides with Alcian Blue-Periodic Acid Schiff ’s reagent (AB-PAS, 
pH 2.5). First, all acid mucins were stained blue with alcian blue, 
and in the subsequent PAS reaction only the neutral mucins 
were stained magenta, as described by Bancroft and Gamble 
(17). Photomicrographs were prepared using light microscopy 
employing Olympus BX61/Camera Color View IIIu (Olympus 
Europa GmbH, Hamburg, Germany) and photo program Cell P 
(Soft Imaging System GmbH, Munster, Germany).
gene expression study
The mRNA levels of selected genes, namely, mitochondrial 
ubiquitin ligase activator of NFκB1 (mul1b), interleukin 1b (il1b), 
tumor necrosis factor a (tnfa), interferon gamma (ifng), acute-
phase serum amyloid A-5 protein (saa5), interleukin-10 (il10), 
annexin A1 (anxa1), and immunoglobulin T (igt) were assessed 
in this study.
RNA Extraction and cDNA Synthesis
Total RNA from the frozen tissue was isolated using acidic phenol 
chloroform extraction and alcohol precipitation method (18). 
RNA quantity was measured by Quant-iT™ RNA broad range 
assay kit (Invitrogen, Carlsbad, USA) and Qubit® 2.0 Fluorometer 
(Life Technologies, Carlsbad, USA), and its integrity was 
confirmed by 1% agarose gel electrophoresis. Reverse transcrip-
tion was carried out using QuantiTect reverse transcription kit 
(Qiagen GmbH, Hilden, Germany) with 1000 ng of total RNA 
in a 20 μl reaction volume, as mentioned in the manufacturer’s 
protocol. The cDNA obtained were subjected to 10-fold dilution, 
before being used in qPCR.
Real-Time PCR (qPCR) and Quantification of  
Gene Expression
The qPCR was performed on StepOnePlus™ Real-Time PCR 
System (Applied Biosystems, Carlsbad, USA) as described by 
Lokesh et al. (19). Fast SYBR® Green PCR Master Mix (Applied 
Biosystems) was used for all reactions. Reactions of 10 μl total 
volume consisted of 5 μl of Fast SYBR® Green PCR Master Mix, 
mixed with 1 μl primer mix (200 nM), 2 μl cDNA (5 ng/μl) and 
2 μl of nuclease free water. Thermal cycling conditions were: ini-
tial holding at 95°C for 20 s followed by 40 cycles of denaturation 
at 95°C (3 s), and annealing/extension at 60°C (30 s). A melt curve 
analysis for each sample was performed to check the specificity 
of the primers. Reactions were performed in duplicate on indi-
vidual fish samples (n = 9). A relative standard curve method was 
employed to calculate the gene expression. The standard curve 
was obtained by running a 6-point threefold dilution series on 
pooled total RNA from all the samples normalized to 1000 ng. 
The dilution series was reverse transcribed and used for qPCR. 
The efficiency of the primers was calculated using the equation 
E = (10−1/m− 1) 100. Using geNorm (20), the normalization factor 
was computed for each of the samples based on the relative quanti-
ties of the two most stable genes (ef1ab and rnap2) from among the 
set of four reference genes – elongation factor 1AB (ef1ab), RNA 
polymerase II (rnap2), hypoxanthine phosphoribosyltransferase 
1 (hprt1), and ubiquitin (ubi). The expression levels of all the 
target genes were then calculated relative to the normalization 
factor (21). The primers for the reference and target genes used 
in the study are given in Table 1.
Protein expression study
Protein expression study was performed on the samples pro-
cured at 24  h after inducing inflammation. Protein samples 
were extracted from DI collected from the two groups (n = 6) to 
perform 2-dimensional gel electrophoresis (2-DE).
Protein Extraction and Two-Dimensional 
Electrophoresis
The extraction of proteins was performed as described by Kulkarni 
et al. (22), with slight modifications. In brief, the frozen intestinal 
samples (~1 g) were ground to a fine powder, and resuspended 
in 2 ml of sterile PBS containing 0.1% protease inhibitor cocktail 
(Sigma). The resulting slurry was subjected to sonication using a 
vibrating probe (Vibra-Cell VC 750, Sonics and Materials Inc., 
TaBle 1 | list of primers used in the present study.
gene Primer sequence Pcr 
efficiency 
(%)
amplicon 
size (bp)
reference
ef1ab TGCCCCTCCAGGATGTCTAC F 98.6 59 GenBank: 
BG933853CACGGCCCACAGGTACTG R
rnap 2 CCAATACATGACCAAATATGA 
AAGG F
96.82 157 GenBank: 
BG936649
ATGATGATGGGGATCTTCC 
TGC R
hprt1 CCGCCTCAAGAGCTACT 
GTAAT F
99.87 255 GenBank: 
BT043501
GTCTGGAACCTCAAACCCT 
ATG R
ubi AGCTGGCCCAGAAGTACAA 
CTGTG F
97 162 GenBank: 
AB036060.1
CCACAAAAAGCACCAAGC 
CAAC R
il1b GCTGGAGAGTGCTGTGG 
AAGA F
102.9 73 GenBank: 
AY617117
TGCTTCCCTCCTGCTCGTAG R
tnfa TGCTGGCAATGCAAAAGTAG F 105.5 178 GenBank: 
AY848945AGCCTGGCTGTAAACGAAGA R
il10 CGCTATGGACAGCATCCT F 102.1 80 GenBank: 
EF165028AAGTGGTTGTTCTGCGTT R
mul1b CCAGAACGACCAACAGGAAGG F 94.1 137 GenBank: 
JF933931GTGAACTCTCTCCAGGAACC 
AGC R
ifng CTAAAGAAGGACAACCGCAG F 97.4 159 GenBank: 
AY795563CACCGTTAGAGGGAGAAATG R
saa5 GCAGCAGCAGTCATCAGTA F 97.8 151 GenBank: 
NM_0011 
46565.1
AGTTCCTTGGGAGTCCATTT R
igt CAACACTGACTGGAACAACAA 
GGT F
96.4 97 GenBank: 
GQ907004 
CGTCAGCGGTTCTGTTTTGGA R
anxa1 GTCAGAATCTTGGTCCTGGTTC F 98.7 98 GenBank: 
CA060324ACTGCCGTAGTGAAGTGTGCT R
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Newtown, USA) for 30 s with a pulse mode of 10 s on ice, and cen-
trifuged (3000 × g, 30 min, 4°C) to obtain crude protein extract 
as the supernatant. Next, a mix of trichloroacetic acid (TCA, 10% 
w/v, Sigma) and dithiothreitol (DTT, 0.1%, Sigma) was added to 
the crude protein extracts and incubated on ice for 30  min to 
obtain a precipitate. After that, a step of centrifugation (10,000 × g, 
30 min, 4°C) was performed to pelletize the precipitate, which 
was then resuspended in cold acetone containing 0.1% DTT 
(Sigma). Employing a vortex mixer this suspension was mixed 
intermittently for 30 min at 20°C. A last round of centrifugation 
(10,000 × g, 30 min, 4°C) yielded purified protein pellets that were 
dissolved in rehydration buffer [9.8M urea (Bio-Rad, Hercules, 
USA), 2% CHAPS (Sigma), 20 mM DTT (Sigma), 0.5% BioLyte 
3-10 (Bio-Rad) and 0.001% bromophenol blue (Sigma)]. A frac-
tion of the solubilized protein was dialyzed using 3 kDa cut off 
Nanosep spin columns (VWR International, Oslo, Norway). The 
quantitation of the dialyzed protein was performed using Qubit® 
Protein Assay Kit and Qubit® Fluorometer (Life Technologies).
For the first dimension, 100 μg (300 μl) of protein from the 
aforementioned step was used to rehydrate 17 cm immobilized 
pH gradient (IPG) gel strips pH 3-10 (Bio-Rad) as per the manu-
facturer’s instructions. Subsequent isoelectric focusing (IEF) was 
performed on the rehydrated IPG strips using the preset method 
within the Protean IEF cell (Bio-Rad), i.e., a maximum of 10,000 V 
was subjected to the IPG strips in 3 slow ramping steps ultimately 
reaching a total of 60,000 vh at a constant temperature of 20°C. 
The electro-focused IPG strips were first reduced and then 
alkylated for 15 min each in equilibration buffer (6M urea, 0.375 
M Tris-HCl, pH 8.8, 2% SDS, 20% glycerol) containing 0.2% DTT 
followed by 0.3% iodoacetamide (Bio-Rad), respectively. The 
second dimension gel electrophoresis of the equilibrated strips 
was performed on a 12.5% polyacrylamide gel in PROTEAN 
II xi system (Bio-Rad) followed by staining with Sypro® Ruby 
protein gel stain (Life Technologies). Further, the gel images were 
captured using ChemiDoc™ XRS imaging system (Bio-Rad).
Gel Image Analyses
The gel image analyses that include spot detection, normaliza-
tion, spot matching, and differential spot volume detection were 
performed using the PDQuest Advanced software (Bio-Rad). 
The differentially expressed spots in the two groups are those 
having a minimum 1.5-fold difference in volumes and statistical 
significance of p < 0.05 by two-tailed Student’s t-test. The volumes 
of the differentially expressed spots were exported to GraphPad 
Prism v5.04 (GraphPad Software Inc., La Jolla, USA) to further 
confirm the statistically significant differences, after checking the 
assumptions of the t-test. Transformations were done wherever 
necessary, and Mann–Whitney test was employed for the analysis 
of non-parametric data.
Protein Identification
The selected protein spots were excised from the preparative 
Sypro® Ruby stained gel loaded with 300 μg of the protein to 
carry out liquid chromatography and tandem mass spectrometry 
(LC-MS/MS). The subsequent in-gel reduction, alkylation fol-
lowed by trypsinization and the LC-MS/MS analyses (ESI Quad 
TOF; Micromass/Waters, Milford, USA), were performed at the 
Tromsø University Proteomics Platform, Norway. The resulting 
data of LC-MS/MS analyses obtained as the peak list files using 
Protein Lynx Global Server Software (version 2.1, Micromass/
Waters) were used to determine the protein identities; using the 
Mascot search engine at UiN, Norway. The search was done in 
the “Actinopterygii (ray-finned fishes)” database. The parameters 
for the search included one missed cleavage by trypsin, peptide 
mass tolerance of 100 ppm, 0.1 Da of fragment mass tolerance, 
carbamidomethyl (of cysteine) for fixed modification, oxidation 
(of methionine) for variable modifications, and 1+, 2+, and 3+ 
for the precursor peptide charge state. The protein inference was 
based on two unique peptides.
statistical analyses
The relative mRNA levels of genes were analyzed using the 
software GraphPad Prism version 5.04. The data before induc-
ing the inflammation is not used for statistical analyses since it 
introduces an additional factor to the current two-factor model, 
and the study focuses on the effect of the microbial additive on the 
induced inflammatory condition. Two-way ANOVA was used to 
find the interaction between the factors (treatment × time point), 
and the effect of the two factors. Bonferroni multiple comparisons 
were performed to understand the difference between two study 
groups at a particular time point and to find the changes between 
two time points for a particular group. All the assumptions were 
checked before performing the tests. Transformations were done 
wherever necessary. If the data were found to be non-parametric, 
Kruskal–Wallis and Dunn’s multiple comparison tests were used. 
The differences were considered significant at p < 0.05.
results
histological Observations
Normal villi contour, distinct lamina propria, enterocytes with 
their basal nuclei, and goblet cells were visible in both groups 
before inducing inflammation (Figure  1A). In the probiotic 
group, there were more goblet cells, intraepithelial lymphocytes 
(IELs), and supranuclear vacuoles (Figure S2 in Supplementary 
Material) in the villi, and more immune cells were evident in the 
lamina propria.
The onset of inflammation was discernible in the control group 
at 4  h after the induction of inflammation (Figure  1B; Figure 
S2 in Supplementary Material), characterized by granulocyte-
(neutrophil) infiltration into the widened lamina propria. On 
the other hand, the probiotic group had more mucus-secreting 
goblet cells and limited infiltration of granulocytes. By 24 h, the 
control group was marked by severe edema, widened intestinal 
villi and lamina propria, dislocated enterocytes and goblet cells, 
and infiltration of granulocytes and lymphocytes (Figure  1C; 
Figure S2 in Supplementary Material). In the probiotic group, 
the inflammatory process became visible only at 24  h, notably 
due to the presence of granulocytes in the lamina propria and 
enlargement of intestinal villi. The speed of recovery was also 
different in the two groups – after 3 weeks, the control group still 
had wider lamina propria and numerous granulocytes compared 
to the probiotic group (Figure 1D; Figure S2 in Supplementary 
Material).
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FigUre 1 | Photomicrographs of the distal intestine of atlantic 
salmon. The images show the micrographs of distal intestine of 
control and probiotic groups (n = 6 fish) before inducing inflammation, 
initial (a) and at 4 h (B), 24 h (c), and 3 weeks (D) after the induction 
of inflammation. PAS positive acid and neutral mucus-filled goblet 
cells (red arrow), enterocytes (white arrow), intraepithelial lymphocytes 
(blue arrow), granulocytes (green arrow), lymphocytes (pink arrow) 
and lamina propria (yellow arrow) are shown in the figure. The 
inflammatory condition is discernable at 24 h in the control group, 
characterized by enlarged intestinal villi and lamina propria (indicated 
by yellow lines) as well as the appearance of numerous granulocytes. 
Scale bar: 20 μm.
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gene expression
The expression of selected genes associated with immune 
and inflammation etiology in the two study groups is shown 
in Figures  2 and 3. An interaction of the two factors (treat-
ment × time point) was detected for anxa1, mul1b, and tnfa. In 
general, prominent differences in the expression of the genes 
between the probiotic and the control groups were seen at 24 h 
after the induction of inflammation. For all the genes, the mRNA 
levels in the control fish were greater than those of the probiotic 
fed fish; the differences being significant in the case of mul1b and 
tnfa (Figure 2). Further, the expression of the different genes in 
the control fish at 24 h was greater compared to the expression 
at 4 h post-inflammation; significant differences were noted for 
mul1b, ifng, and il10 (Figures 2 and 3). In addition, the control 
fish had lower levels of genes at 3 weeks compared to the levels at 
24 h; significant differences were detected for mul1b, il1b, and tnfa 
(Figure 2). Further, the level of anxa1 at 3 weeks is higher in the 
probiotic group compared to the levels at 4 and 24 h (Figure 3).
Protein expression
Based on the alteration of the selected genes, the protein 
expression was assessed only at 24  h after inducing inflamma-
tion. From among the many protein spots resolved in the gels, 
the differentially expressed spots corresponded to five inferred 
proteins. Calreticulin (1.58-fold, Calr), Proteasome subunit alpha 
type-5 (2.96-fold, Psma5) and Trypsin-1 (3.91-fold, Trp1) were 
overexpressed at 24  h after inducing inflammation, in the DI 
of Atlantic salmon that were on microbial additive-coated feed 
compared to those in the control group (Figure 4 and Tables 2 
and 3). On the other hand, Cathepsin B (0.51-fold, Ctsb) and 
alpha-N-acetylgalactosaminidase (0.49-fold, Naga), were the 
underexpressed proteins.
Discussion
Probiotics promote gut epithelial homeostasis by controlling the 
altered commensal bacterial composition, preventing patho-
genic bacterial invasion, enhancing intestinal epithelial barrier 
function, and maintaining a balance between Th1/Th2 and 
Treg cells (23–25). The present study has obtained interesting 
findings in fish to support the beneficial properties of probiotics 
that are well-documented in the case of terrestrial animals (26). 
FigUre 2 | relative mrna levels of mul1b, il1b, tnfa, ifng, and saa5 in 
the distal intestine of atlantic salmon. The distal intestinal gene 
expression of control and probiotic groups (n = 9 fish) before inducing 
inflammation (initial) and at 4 h, 24 h, and 3 weeks after the induction of 
inflammation are shown in the figure. Solid connectors indicate significant 
differences (p < 0.05) between the study groups at a particular time point. 
Dashed connectors indicate significant difference (p < 0.05) between the 
levels at two time points of a particular study group. Values are presented as 
mean ± SEM.
FigUre 3 | relative mrna levels of il10, igt, and anxa1 in the distal 
intestine of atlantic salmon. The distal intestinal gene expression of 
control and probiotic groups (n = 9 fish) before inducing inflammation (initial) 
and at 4 h, 24 h, and 3 weeks after the induction of inflammation are shown 
in the figure. Solid connectors indicate significant differences (p < 0.05) 
between the study groups at a particular time point. Dashed connectors 
indicate significant difference (p < 0.05) between the levels at two time points 
of a particular study group. Values are presented as mean ± SEM.
August 2015 | Volume 6 | Article 4097
Vasanth et al. Microbial additive abates intestinal inflammation
Frontiers in Immunology | www.frontiersin.org
In human beings, probiotics have been used to treat intestinal 
infection and inflammation (27, 28), and in this study, the ability 
of a microbial feed additive to suppress/alleviate the inflamma-
tory responses in the distal intestinal segment of Atlantic salmon 
was assessed.
intestinal Micromorphology indicates that the 
Microbial Feed additive May have a Protective 
Function
The cardinal characteristics of an inflamed tissue include tis-
sue damage, infiltration of lymphocytes/neutrophils, and tight 
junction damage that increases cellular permeability (29, 30). 
Tissue inflammation occurs when the mucosal barrier integrity 
is disrupted, causing increased uptake of luminal antigens to 
activate T cells, which is followed by the release of a number 
of inflammatory mediators such as cytokines and chemokines 
(TNFα and interleukins) – this causes the further recruitment 
of T cells and upregulation of adhesion molecules, which leads 
to homing of neutrophils/lymphocytes from blood to inflamed 
tissues (31). In the present study, the influx of inflammatory 
cells and disturbance of normal intestinal structure occurred 
in the control group by 4 h after the induction of inflammation. 
FigUre 4 | representative 2-De gels generated using protein samples 
from the distal intestine of atlantic salmon. The protein spots in the 
control and probiotic groups (n = 6 fish) at 24 h after the induction of 
inflammation are shown in the figure. Intestinal proteins from the fish were 
isoelectrically focused on 17 cm IPG strips (pI 3-10) and were subjected to 
12.5% SDS-PAGE. The 2-DE gels were stained with Sypro®Ruby protein gel 
stain, and the spots were annotated using the data from LC-MSMS. The spot 
numbers in the gels correspond to the protein identities mentioned in Table 2.
TaBle 2 | information on the proteins that were altered significantly in atlantic salmon intestine.
spot no. Protein accession number and 
details
apparent 
pi/MW (kDa) 
Protein 
score
sT a Mp/
Up b
sU c Peptide sequenced
IP1 Ssa.34432, Clone ssal-rgf-517-369 
Calreticulin precursor putative
3.5/86.5 252 54 3/3 252 FYgDaeaDK eaeeFgneTWgTTK 
FYgDaeaDKglQTsQDar
IP2 NP_001134432, Proteasome 
subunit alpha type-5 [Salmo salar]
4.4/33.2 108 43 2/2 108 iVeiDThigcaMsgliaDaK  
TFhMYsKeeleDViK
IP3 Ssa.7877, Transcribed 
locus, strongly similar to 
NP_001117776.1 procathepsin B 
precursor [Oncorhynchus mykiss]
5.7/12.3 817 54 8/8 817 eQQiMselYK cVsecnagYTPsYVK gKDecgieseiVagiPr 
TgVYQhVTgQMlgghaiK ngPVeaaFsVYeDFllYK 
DgPVeaaFsVYeDFllYK DQgscgscWaFgaaeaisDr 
enDTPYWlVansWnTDWgDngFFK
IP4 Ssa.8176, nagab 
Alpha-N-acetylgalactosaminidase
5.3/33.0 1430 54 16/16 1430 asalVFFsr nciseVlFr iTiDaQTFaDWK sgieVFWrPlsDK 
FrcDiDcQnDPK VaiginQDPMgVQgr FPsgiPnlasYihDr 
YQaslgQlnYTTgsYK rFPsgiPnlasYihDr 
elgYVYVniDDcWasK sQMalWaiMaaPlFMsnDlr 
lgiYgDMgTlTcggYPgTPlDK 
WnDPDMlVVgDFglsMDQsr 
sQMalWaiMaaPlFMsnDlr WnDPDMlVVgDFglsMDQsr 
lgiYgDMgTlTcggYPgTPlDK
IP5 Ssa.628, trp-ia Trypsin IA 5.3/61.3 256 54 3/3 256 VTegseQFisssr hPnYssYniDnDiMliK 
lgehniQVTegseQFisssr
aSignificant threshold score.
bTotal matched peptides/total unique peptides.
cTotal score of unique peptides.
dUnique peptide sequences are in bold.
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However, such changes were not evident at this time point in 
the probiotic group that had more goblet cells and IELs. An 
earlier study on red tilapia (Oreochromis niloticus) has also 
reported the abundance of IELs in the posterior intestine of 
the fish upon P. acidilactici-feeding (13). Another study on the 
same fish species that used Bacillus amyloliquefaciens as pro-
biotic reported more mucus-secreting cells and IELs (12). The 
control group had many inflammatory cells, and greater dam-
age of intestinal cells at 24 h compared to the probiotic group. 
In mammals, acute inflammation is characterized by a large 
number of neutrophils’ recruitment (within minutes following 
inflammation stimuli, peaking by 24–48  h) into the lamina 
propria, with their accompanying macrophages (appearing at 
the inflammation sites within 2–3 h, and increasing following 
a time lapse), and lymphocytes (arriving a few days after) (32, 
33). The presence of many inflammatory cells in the control 
group at 24 h may be indicating the severity of inflammation. 
At this time point, the key inflammatory cytokines (described 
later) were induced, all pointing to the acute inflammation in 
the control group. The inflammatory process in the probiotic 
group, which had less granulocyte-infiltration at 4  h, became 
visible at 24 h. It is known that reduction in size and number of 
goblet cells is a characteristic feature of human ulcerative colitis 
(34). Further, the soluble proteins from Lactobacillus GG (LGG) 
in fermented milk activated epidermal growth factor receptor 
(EGFR) and anti-apoptotic factor (Akt) in young adult mouse 
colon cells, and this activation is attributed to the reduction in 
colitis (35). In the current study, the ability of the microbial 
additive in preventing inflammatory responses is evident from 
the subdued inflammation in the probiotic group, based on 
intestinal micromorphology.
The speed of recovery in the probiotic group was evident 
since even after 3  weeks the control group had wider lamina 
propria and numerous granulocytes. Mammalian epithelial 
turnover occurs every 3–5  days (36), and during epithelial 
restitution – with the help of antimicrobial peptides, defensins, 
regenerating protein family – intestinal cells proliferate, expand, 
migrate, and differentiate, and mucins from goblet cells prevent 
translocation of commensal bacteria (30). It is reported that in 
Atlantic salmon, the distal intestinal epithelial turnover occurs 
after 28 days (37). In mammals, during intestinal wound healing, 
the denuded area will be rapidly re-sealed by the migration of 
epithelial cells adjacent to injury, epithelial cell proliferation, 
maturation, and differentiation (38). In the control fish of the 
present study, intestinal epithelial cells that were more damaged 
than those in the probiotic group, were repaired, and recon-
structed by 21 days.
inflammation associated responses, as 
evidenced by gene expression
The molecular mapping of genes associated with immune and 
inflammation etiology aided in comparing the level of inflam-
mation between the two study groups. Upon immune challenge 
the mRNA of mul1b, the activator of NFκB1, is upregulated in 
Atlantic salmon (39). Effector molecules of the innate immune 
system play an important role in initiating immune tolerance, 
intestinal epithelial cell proliferation and tissue repair to main-
tain intestinal homeostasis, and NFκB, the main mediator, has 
canonical (proinflammatory) and alternative (anti-inflammatory) 
pathways (40, 41). The possible NFκB suppression at 24 h (based 
on mul1b downregulation) in probiotic group and the upregula-
tion of the proinflammatory cytokine levels in the control group 
(mul1b, il1b, ifng, and tnfa – time-wise variations; tnfa – control 
vs probiotic) suggest that the immune responses are counteract-
ing the inflammation. The significantly high expression of the key 
markers of inflammation only in the control group indicates the 
extremity of inflammation. In a study on tilapia, 3 weeks feeding 
with P. acidilactici upregulated tnfa in the mid intestine of the fish 
(42), whereas in rainbow trout (Oncorhynchus mykiss), 3 weeks of 
Lactobacillus plantarum feeding led to the upregulation of intes-
tinal il8 and not tlr5 or igt (43). In the current study, there was an 
apparent upregulation of tnfa (though not statistically significant) 
in the probiotic group at the initial time point (after 3 weeks feed-
ing). In mammals, probiotics promote gut epithelial homeostasis 
by upregulation of IL10 and TGFβ, downregulation of IL12, TNFα, 
and IL8, and by lowering the NFκB activation in lamina propria 
mononuclear cells to counter inflammatory responses (23–25, 44, 
45). Intake of probiotic, mainly the Lactobacillus strain, helped 
in balancing the pro- and anti-inflammatory cytokines (46), 
thereby attenuating proinflammatory activity. Administration of 
L. plantarum and L. brevis reduced IL1β, TNFα, and IFNγ, as well 
as the protein expressions of IL1β and IL6, and the signs of colitis 
in DSS-induced colitic mice (47). The soluble proteins produced 
by probiotic organisms are found to reduce the TNF-induced 
epithelial damage and apoptosis in cultured mouse colon explants 
(48). The microbial feed additive used in this study might have 
helped to balance the pro- and anti-inflammatory cytokines and 
maintain intestinal homeostasis in Atlantic salmon.
Elevation of immunoglobulin in response to probiotic feeding 
has been reported in other studies on animals, including fish (11). 
Further, tissue IgG1 and IgG2a were lower in the inflammatory 
regions in mice fed LAB (Bifidobacterium breve, B. bifidum, and 
Lactobacillus acidophilus) fermented milk than those fed saline 
and unfermented milk (49). Likewise, at 24 h the levels of igt in 
the intestine of Atlantic salmon fed on probiotic was apparently 
low, although not significantly. anxa1 suppresses the inflamma-
tory responses and is known to possess both gastro-protective 
and anti-inflammatory properties (50), as seen in the repair of 
mice intestinal mucosal epithelium (51). In Atlantic salmon of 
the probiotic group, the recovery by the third week from the 
minor inflammatory responses at 24  h may have been aided, 
by among others, the overexpression of anxa1. The continuous 
supplementation of the microbial additive, even after inducing 
inflammation could have positively helped the fish to restore its 
intestinal integrity.
TaBle 3 | expressional changes of the identified proteins in the distal 
intestine of atlantic salmon.
spot no. Protein name Fold change 
IP1 Calreticulin precursor, Calr 1.58 ↑
IP2 Proteasome subunit alpha type-5, Psma5 2.96 ↑
IP3 Cathepsin B precursor, Catsb 0.51 ↓
IP4 Alpha-N-acetylgalactosaminidase, Naga 0.49 ↓
IP5 Trypsin-1A precursor, Trp1 3.91 ↑
↑ indicates overexpression and ↓ indicates underexpression.
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Although the intestinal micromorphological observations at 
4 h point to the differences in inflammatory responses between 
the control and the probiotic groups, gene expressional differ-
ences become visible only when the inflammation in the control 
group is severe. At 24 h, mul1b and tnfa in the control group are 
higher compared to those in the probiotic group. The higher levels 
of mul1b and ifng at 24 h compared to the values at 4 h coincide 
with the severity of inflammation at 24 h, in the control group. 
In addition, the higher levels of mul1b, il1b, and tnfa at 24  h 
compared with the levels at 3 weeks also reflect the histological 
observations. It should be noted that the anti-inflammatory gene, 
il10, was higher only in the control group at 24 h compared to the 
value at 4 h. On the other hand, even though the inflammation in 
the probiotic group is not as severe as that in the control group, 
the gastro-protection linked gene anxa1 is high at 3 weeks in the 
probiotic group, indicating the protective mechanisms enabled by 
the microbial additive.
Proteins that contribute to Protective 
responses in the intestine
Five proteins were differentially expressed in the DI of Atlantic 
salmon that were on microbial additive-incorporated feed com-
pared to those in the control group.
Calreticulin, CALR (or calregulin/CRP55/CaBP3/calseques-
trin-like protein/endoplasmic reticulum resident protein 60, 
ERp60) is a multifunctional endoplasmic resident chaperone 
protein which has also been identified in the cytoplasm, cell mem-
brane, and extracellular matrix. The non-endoplasmic reticulum 
functions of calreticulin has also been studied (52) – calreticulin-
induced cell proliferation and faster healing were demonstrated 
in murine diabetic wound model. Adhesion of epithelial cells to 
their neighbors and extracellular matrix is governed by adhesion 
complexes, and the integrin-interacting CALR is associated with 
the adhesion complex of the focal junctions (53). Thin calreticu-
lin-containing tubules that encircle mucin granules of goblet cells 
are in close contact with endoplasmic reticulum tubules (54). The 
increased presence of the goblet cells and the significant upregu-
lation of Calr in the probiotic group point to the key role of this 
protein in many of the cellular and immunoregulatory functions, 
which help to counter the inflammation.
Proteasome subunit alpha type-5 (PSMA5) is a proteinase com-
plex that performs the non-lysosomal ATP/ubiquitin-dependent 
peptide-cleavage. The α-ring of the proteasome is involved in 
recognition, binding of substrates as well as their entry into the 
proteasome chamber (55). The inner rings of the constitutive 
proteasome complex that contain proteolytic centers are encoded 
by 3 β-subunits (β1, β2, and β5), which get converted to immuno-
subunits upon stimulation by IFNγ, to form immunoproteasome 
(55, 56). Processing of class I MHC peptides is undertaken by the 
immunoproteasome, which displays increased chymotrypsin-like 
activity than its constitutive counterpart (56). However, in the 
present study, ifng was not upregulated and it is not the β-subunit 
that is overexpressed in the probiotic group at 24 h. Information 
on immunoproteasome in fish is scanty. Some immune-related 
proteasome subunits are present in hagfish, Eptatretus bur-
geri – 20S proteasome subunit, a and b type, 1–7 and proteasome 
activator subunit 3 (57). psma5, psmb3, and psmd6 were lower in 
triploid, and immature diploid rainbow trout, O. mykiss, and their 
expression has been linked to the feed rations (58). The microbial 
additive could have increased Psma5 to enhance its recognition 
for further processing of the microbial substrate.
The significant enhancement of Trypsin-1 (Trp1) or cationic 
trypsinogen in the intestine of the probiotic group at 24  h is 
an evidence on the homeostatic response in the fish. There are 
reports that proper administration of trypsin and chymotrypsin 
effectively reduces inflammation and edema (59). Enterocytes and 
goblet cells produce enteropeptidase that activates trypsinogen to 
trypsin (60), and trypsin stored as trypsinogen in paneth cells 
processes human paneth cell defensins (61). Trypsin was found 
to localize on mucus-secreting surface epithelial cells of Atlantic 
salmon, and the protein is suggested to be a part of non-specific 
immune defense (62). Although the upregulation of trypsin-like 
activity in the distal intestinal wall was suggested to be associated 
with subacute enteritis severity (63), Trp1 overexpression was 
noted in microbial additive-fed salmon that had subdued inflam-
matory responses. The overexpressed protein may be pointing to 
the link with intestinal immune defense.
Cathepsin B (CTSB), a lysosomal enzyme belonging to pepti-
dases, helps in intracellular degradation and protein turnover 
(64). CTSB processes antigens, mainly to activate Th2 cells in 
mice (65), indicating the immune response regulatory function 
of this molecule. Upregulation of this enzyme is linked to condi-
tions such as cell death and inflammation (66, 67). Therefore, the 
underexpression of Ctsb precursor and the mRNA levels of il1b, 
in Atlantic salmon, may have led to the milder inflammatory 
condition in the probiotic group at 24 h.
Alpha-N-acetylgalactosaminidase (NAGA), a glycoside 
hydrolase, is present in the lumen of human lysosomes (68). This 
glycosidase helps in the degradation of mucin carbohydrates and 
removes terminal Alpha-N-acetylgalactosamine residues from 
glycolipids and glycoproteins (69). When NAGA deglycosylates 
Gc protein (serum vitamin D3-binding protein) its conversion to 
the precursor of a principal macrophage-activating factor, MAF is 
not possible, and immunosuppression will be the net result (70). 
The underexpression of Naga in Atlantic salmon could be sug-
gesting that probiotic feeding may not cause immunosuppression.
conclusion
The findings from the present study provide evidence on the role 
of the microbial additive in intestinal homeostasis. The milder 
and delayed inflammatory responses in the probiotic group con-
trast with the rapid and severe inflammatory pathology in the DI 
of fish that did not receive the microbial supplement. The speed 
of recovery was also different in the two groups – the probiotic 
fed fish overcame the inflammatory challenge rapidly, possibly 
because of the protective functions that prevailed in this fish.
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